Columbia University

Naomi Berrie Diabetes Center

Naomi Berrie Diabetes Center
1150 St. Nicholas Avenue
New York, NY 10032
United States
Call 212-851-5465 Email this location
Columbia University is one of twenty-five type 1 diabetes TrialNet International Clinical Centers at the forefront of type 1 diabetes research. Led by Robin Goland, MD, the TrialNet team at Columbia University is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Our Team

Principal Investigators 
Robin
Goland
MD
Dr. Robin Goland, J. Merrill Eastman Professor of Clinical Diabetes, Professor of Medicine and Pediatrics at Columbia University, directs the patient care and clinical research programs at the Berrie Center. She was instrumental in establishing the Naomi Berrie Diabetes Center in July 1998. Under the leadership of Dr. Goland and Berrie Center Co-Director Dr. Rudolph Leibel, the Berrie Center has become recognized nationally and internationally for excellence and innovation in patient care and research in diabetes. Dr. Goland has a B.A. from Harvard University and an M.D. from Columbia University College of Physicians & Surgeons. She was a resident and chief medical resident at NY-Presbyterian Hospital and did her endocrinology research training at Columbia University.
Magdalena
Bogun
MD
Kristen
Williams
MD
Rachelle
Gandica
MD
Research Coordinators 
Sarah
Pollak
RN
Kimberly
Pope
RN
Eberechi Cecilia
Uche
BA

Regional Affiliates

Albany

Albany Medical College
MC141, 25 Hackett Blvd, Albany, NY 12208

Buffalo

The Childrens Hospital, Buffalo
219 Bryant St - Endocrinology, Buffalo, NY 14222

Hackensack

Hackensack University Medical Center
30 Prospect Ave., WFAN Bldg., Hackensack, NJ 07601

Lake Success

Cohen Childrens Medical Center
1991 Marcus Ave. Suite M100, Lake Success, NY 11042

Mineola

Winthrop University Hospital
101 Mineola Blvd., 2nd Floor, Mineola, NY 11501

Morristown

Morristown Memorial Hospital
100 Madison Ave., Box 53, Morristown, NJ 07962

New Brunswick

UMDNJ Robert Wood Johnson Medical School
89 French St, New Brunswick, NJ 08901

Rochester

University of Rochester
601 Elmwood Ave., Box 777, Room 4-5227, Rochester, NY 14642

Syracuse

Joslin Center at SUNY Upstate Medical University
505 Irving Ave. IHP Room 1232B, Syracuse, NY 13210

Research Studies

Risk Screening

Pathway to Prevention

If you have a relative with T1D, you’re in a unique position to help us learn more about the disease and how to stop it. The first step is to sign up for Pathway to Prevention screening to determine your risk of developing T1D.

More

Prevention Study

Abatacept

TrialNet is testing the drug abatacept to see if it can delay or prevent progression of early stage T1D (stage 1 to stage 2) and ultimately prevent clinical diagnosis (stage 3). In earlier studies for people newly diagnosed (stage 3), abatacept helped slow down disease progression.

More

Teplizumab

We are testing the drug teplizumab to see if it can delay or prevent progression of early stage T1D (stage 2) and prevent clinical diagnosis (stage 3). In earlier studies in people newly diagnosed (stage 3), teplizumab helped to prolong insulin production.

More

Longterm

Long-Term Investigative Follow-Up in TrialNet (LIFT)

Once your study ends, we're still here for you. Participant monitoring and continued involvement helps us learn more about T1D.

More